Praiss, A., Moukarzel, L., Zhu, Y., Derakhshan, F., Hoang, T., Pesci, G., Green, H., Hanlon, E., Gardner, G., Roche, K. L., Abu-Rustum, N., Sonoda, Y., Zivanovic, O., Chi, D., Weigelt, B., & Zamarin, D. (2023). Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer (187). Gynecologic Oncology, 176, S75–S76. https://doi.org/10.1016/j.ygyno.2023.06.573

Diggs, A., Dioun, S., Chen, L., St. Clair, C., de Meritens, A. B., Hou, J., Khoury-Collado, F., & Wright, J. (2023). Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy (2204). Gynecologic Oncology, 176, S259. https://doi.org/10.1016/j.ygyno.2023.06.324

Diggs, A., Huang, Y., Melamed, A., Szamreta, E., Monberg, M., & Wright, J. (2022). EP054/#637 Patterns of use of primary chemotherapy and first-line chemotherapy for recurrence among patients with cervical cancer. E-Posters. https://doi.org/10.1136/ijgc-2022-igcs.145

Besharati, S., Liu‐Jarin, X., Chen, X., & Cimic, A. (2022). An unusual case of carcinoma with mesonephric‐like features with a spindle cell component diagnosed on the Pap test of the uterine cervix: Cytomorphologic and immunophenotypic features and diagnostic pitfalls. Diagnostic Cytopathology, 50(11). Portico. https://doi.org/10.1002/dc.25009

Dioun, S., Chen, L., Gockley, A., Melamed, A., St Clair, C., Tergas, A., Hou, J., Collado, F., & Wright, J. (2021). OP013/#417 Cost-effectiveness of dostarlimab in advanced recurrent deficient mismatch repair endometrial cancer patients. Oral Featured Posters, A16.1-A16. https://doi.org/10.1136/ijgc-2021-igcs.30